Search Results - Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Guidance for industry ANDAs, pharmaceutical solid polymorphism, chemistry, manufacturing and controls information.

    Published 2007
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  2. 2

    Guidance for industry revising and ANDA labeling following revision of the RLD labeling.

    Published 2000
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  3. 3

    Guidance for industry major, minor, and telephone amendments to abbreviated new drug applications.

    Published 2001
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  4. 4

    Guidance for industry potassium chloride modified-release tablets and capsules, in vivo bioequivalence and in vitro dissolution testing.

    Published 2005
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  5. 5

    Guidance for industry bioequivalence recommendations for specific products.

    Published 2007
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  6. 6

    Guidance for industry alternate source of the active pharmaceutical ingredient in pending ANDAs.

    Published 2000
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  7. 7

    Guidance for industry listed drugs, 30 month stays, and approval of ANDAs and 505(b)(2) applications under Hatch-Waxman, as amended by the Medicare Prescription Drug, Improvement,...

    Published 2004
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  8. 8

    Guidance for industry ANDAs, impurities in drug substances.

    Published 2009
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  9. 9

    Guidance for industry ANDAs, impurities in drug products.

    Published 2005
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Government Document Electronic eBook
  10. 10

    Orange book : approved drug products with therapeutic equivalence evaluations.

    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Connect to online resource
    Online Access
    Connect to online resource
    Government Document Continuing Resource
  11. 11

    Approved drug products with therapeutic equivalence evaluations.

    Published 1985
    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Request a PDF (UCB only)
    Government Document Serial
  12. 12

    Approved drug products with therapeutic equivalence evaluations.

    “…Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs…”
    Online Access
    Online Access
    Connect to online resource
    Online Access
    Connect to online resource
    Government Document Serial
Search Tools: RSS Feed Save Search